News

Hologic price target lowered to $75 from $83 at RBC Capital
RBC Capital lowered the firm’s price target on Hologic (HOLX) to $75 from $83 and keeps a Sector Perform rating on the shares as part of a ...
Leerink Partnrs Issues Pessimistic Estimate for DGX Earnings
Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...
Quest Diagnostics (NYSE:DGX) Earns Buy Rating from Analysts at Redburn Atlantic
Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...
Investor's Business Daily on MSN5d
Why IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-Off
Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.
Fintel on MSN6d
Redburn Atlantic Initiates Coverage of Quest Diagnostics (DGX) with Buy Recommendation
Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...
Quest Diagnostics initiated with a Buy at Redburn Atlantic
Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...